Did The Liquidity Problem in Tokenised Finance Just Get Solved? How Midas and Symbiotic Are Making T+0 Redemptions a Reality
- Shawn Jhanji
- Apr 30
- 4 min read
For years, the tokenisation industry has been making a promise it could not always keep. Tokenised assets, the pitch goes, are liquid by design, tradeable around the clock, redeemable on demand and freed from the settlement delays that have long frustrated investors in traditional finance. The reality has been more complicated. Until now.
On 28 April 2026, Midas and Symbiotic jointly announced the launch of an instant liquidity architecture for tokenised real-world assets that delivers on that original promise - T+0 atomic settlement for on-chain investment products, powered by a request-for-quote (RFQ) system built on Symbiotic Core version two.
For UK startup founders and investors watching the tokenisation space, this is not a minor infrastructure update. This matters! It is the resolution of one of the sector's most stubborn structural weaknesses, and it has significant implications for how tokenised equity and other private assets could be designed and sold in the years ahead.
The Problem They Solved
The liquidity problem in tokenised assets has always been a quiet embarrassment for the sector. Investors were told they could exit positions in tokenised funds, treasuries, or credit products at any time — but in practice, redemptions required issuers to unwind underlying positions, convert to cash, and settle across chains and rails. The process often took hours or, in more complex structures, days.
The standard workaround was pre-funded liquidity buffers: issuers set aside idle capital to handle redemptions, essentially paying a permanent liquidity tax that ate into yields. For an asset class being sold on efficiency, it was an uncomfortable compromise.
Midas, the Berlin-based tokenised investment platform founded in 2024 by Dennis Dinkelmeyer (formerly Goldman Sachs), Romain Bourgois (formerly Ondo Finance), and Fabrice Grinda (FJ Labs), had already built a reputation as one of the most sophisticated issuers in the RWA space with $1.7 billion in tokenised assets issued and $37 million in yield distributed since launch. But the redemption bottleneck remained.
How the New System Works
The Symbiotic Instant Liquidity integration removes the need for pre-funded buffers entirely. When an investor submits a redemption request through Midas, the system broadcasts it to a network of Symbiotic-registered market makers and curators via an on-chain RFQ auction. Market makers respond with live bids, the best price is selected, and the entire transaction — asset transfer and settlement — executes atomically in a single on-chain operation.
The result is genuine T+0 settlement with no idle capital on the issuer's side. Market makers do not need to pre-fund inventory either; they earn the bid-ask spread at the point of execution and are incentivised to participate precisely because capital is only deployed when a trade clears.
The initial liquidity capacity of the Midas Staked Liquidity system is up to $40 million, with scope to scale as market maker participation grows. Symbiotic Core v2 provides the underlying coordination and settlement infrastructure.
Why This Matters Beyond Midas
Midas is not the only tokenised asset issuer in the world, but the Symbiotic integration is significant because it is built as an open architecture. The RFQ system and liquidity layer are designed to be portable — any tokenised asset issuer operating on compatible infrastructure could, in principle, plug in.
This matters enormously for the broader tokenised equity conversation. One of the persistent objections from institutional investors considering exposure to tokenised private company shares has been the question of exit: if the underlying asset is illiquid (a private company's equity), how does the tokenised wrapper genuinely improve matters?
The answer has historically been nuanced and unsatisfying.
A well-designed instant liquidity layer changes that calculation. It does not make the underlying asset liquid — private equity is private equity — but it removes friction at the token layer, meaning that secondary market dynamics can develop more organically around tokenised instruments. That is a precondition for tokenised startup equity becoming a mainstream investable category rather than a niche experiment.
The Context: Midas's $50 Million War Chest
This announcement arrives a month after Midas closed a $50 million Series A led by RRE Ventures and Creandum, with participation from Franklin Templeton, Coinbase Ventures, Framework Ventures, HV Capital, North Island Ventures, FJ Labs, and GSR Ventures. The round was notable for its mix of crypto-native and traditional institutional backers — a signal of how the tokenised investment space is maturing.
Midas's roadmap was always about building infrastructure that the sector needed, not just another tokenised product. The Symbiotic integration is the clearest expression yet of that strategy.
Key Takeaways
Midas and Symbiotic have launched a T+0 instant liquidity system for tokenised assets, eliminating the need for pre-funded redemption buffers.
The RFQ-based architecture allows market makers to bid competitively on redemptions in real time, with atomic on-chain settlement.
No idle capital required — either from the issuer or the market makers — making the system highly capital-efficient.
Initial capacity is $40 million, with the system designed to scale as participation grows on Symbiotic Core v2.
The broader implication is significant: solving liquidity at the token layer is a precondition for tokenised equity and other illiquid asset classes to reach institutional scale.
Sources:
Disclaimer:
This article is provided for general information only and does not constitute legal, financial, or investment advice. The regulatory treatment of tokenised assets and digital securities varies by jurisdiction and continues to evolve. Readers should seek independent professional advice before making any financial, legal, or regulatory decisions.
Comments